1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 21 SEPTEMBER 2015

Cancer Drug News 21 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Biologic Investment Sets AstraZeneca On Course For Long-Term Growth
Industry Brief - BriaCell Initiates Development Of BriaDx Companion Diagnostic
Industry Brief - FDA Accepts Amgen's Kyprolis sNDA For Priority Review In Relapsed MM
Industry Brief - TG/FDA Reach SPA Agreement On Phase III Combination Study In CLL
Industry Brief - ERYTECH Seeks EU Approval For Graspa In ALL
Industry Brief - EMA Grants SL-401 ODD For AML
Industry Brief - sNDA For Imbruvica In CLL Submitted To FDA
Industry Brief - Oxis Licenses Worldwide Rights For DT2219ARL
Industry Brief - US FDA Grants Priority Review For Daratumumab For Multiple Myeloma
Industry Brief - RedHill Secures SBIR Grant For Yeliva Phase II MM Study
Industry Brief - Takeda's Ixazomib Granted Priority Review for r/r MM
Industry Brief - FDA Grants Priority Review for Ofatumumab As Relapsed CLL Maintenance Therapy
Industry Brief - New Data Support Rationale Behind OncoMed's Tarextumab
Industry Brief - Transgene Presents OS Data From TG4010 Phase IIb NSCLC Trial
Industry Brief - Helsinn/Bial Sign Anamorelin Licensing Deal In Select Territories
Industry Brief - FDA Grants Genentech's Alectinib Priority Review For ALK+ NSCLC
Industry Brief - FDA Grants Breakthrough Therapy Designation To Opdivo For Advanced RCC
Industry Brief - FDA Grants Fast Track Designation To BioCancell's BC-819
Industry Brief - Enumeral Achieves First Milestone In Merck Collaboration
Industry Brief - Masitinib Gains ODD For Oesophagogastric Adenocarcinoma
Industry Brief - Can-Fite's CF102 Gains FDA Fast Track Designation For HCC
Industry Trend Analysis - Liquid Biopsy Market Gaining Momentum
Industry Trend Analysis - Amgen Pipeline Needs To Increase Generation Of Marketable Products
Industry Trend Analysis - Oncology Therapies To See Strong Demand Ahead
Industry Brief - Cancer Research UK/MedImmune Launch Biotherapeutics Research Centre
Industry Brief - Janssen Seeks Daratumumab Approval In Europe For MM
Industry Brief - Kancera/Acturum Sign Deal To Evaluate AZD8797
Industry Brief - Agenus Raises Cash To Advance Immuno-Oncology Programmes
Industry Brief - Taj Accura Expands Global Oncology Portfolio
Industry Brief - Dosing Begins In BIND-014 Phase II Trial In Four Tumour Histologies
Industry Brief - Enrolment Completed In Adcetris Phase III CTCL Trial
Industry Brief - Akynzeo Launched In UK
Industry Brief - FDA Accepts Wellstat's Uridine Triacetate NDA For Review
Industry Brief - FDA Accepts Sustol NDA For Review
Industry Brief - AstraZeneca/University Of Manchester Sign Clinical Bioinformatics Deal
Industry Brief - Cancer Conferences - November/December 2015

Table Of Contents

Cancer Drug News 21 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.